Applied Microarrays’ ’09 sales up 50% on demand for custom projects

December 8, 2009

By Flinn Foundation

[Source: Genomeweb] – According to the firm’s CEO, the majority of the company’s sales come from contract manufacturing, while sales of legacy CodeLink bioarray products now account for less than a tenth of AMI’s total revenues.

For more information: Applied Microarrays’ ’09 Sales Up 50 Percent on Demand for Custom Projects